139 related articles for article (PubMed ID: 24811347)
1. The carbamoylmannose moiety of bleomycin mediates selective tumor cell targeting.
Bhattacharya C; Yu Z; Rishel MJ; Hecht SM
Biochemistry; 2014 May; 53(20):3264-6. PubMed ID: 24811347
[TBL] [Abstract][Full Text] [Related]
2. Modified bleomycin disaccharides exhibiting improved tumor cell targeting.
Madathil MM; Bhattacharya C; Yu Z; Paul R; Rishel MJ; Hecht SM
Biochemistry; 2014 Nov; 53(43):6800-10. PubMed ID: 25272367
[TBL] [Abstract][Full Text] [Related]
3. Selective tumor cell targeting by the disaccharide moiety of bleomycin.
Yu Z; Schmaltz RM; Bozeman TC; Paul R; Rishel MJ; Tsosie KS; Hecht SM
J Am Chem Soc; 2013 Feb; 135(8):2883-6. PubMed ID: 23379863
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate dependent targeting of cancer cells by bleomycin-microbubble conjugates.
Chapuis JC; Schmaltz RM; Tsosie KS; Belohlavek M; Hecht SM
J Am Chem Soc; 2009 Feb; 131(7):2438-9. PubMed ID: 19187019
[TBL] [Abstract][Full Text] [Related]
5. The disaccharide moiety of bleomycin facilitates uptake by cancer cells.
Schroeder BR; Ghare MI; Bhattacharya C; Paul R; Yu Z; Zaleski PA; Bozeman TC; Rishel MJ; Hecht SM
J Am Chem Soc; 2014 Oct; 136(39):13641-56. PubMed ID: 25184545
[TBL] [Abstract][Full Text] [Related]
6. Structural features facilitating tumor cell targeting and internalization by bleomycin and its disaccharide.
Yu Z; Paul R; Bhattacharya C; Bozeman TC; Rishel MJ; Hecht SM
Biochemistry; 2015 May; 54(19):3100-9. PubMed ID: 25905565
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.
Li B; Zheng YB; Li DD; Zhen YS
J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor effect of targeted nanoliposomal bleomycin.
Chiani M; Azadmanesh K; Shokrgozar MA; Mehrabi MR; Akbarzadeh A; Norouzian D
Chem Biol Drug Des; 2017 Nov; 90(5):953-961. PubMed ID: 28498511
[TBL] [Abstract][Full Text] [Related]
9. A gulose moiety contributes to the belomycin (BLM) disaccharide selective targeting to lung cancer cells.
Zhou C; Ye W; Cao Y; Wang M; Qi D; Liao G; Li H; Huang W; Chen W; Wang X; Zhou W
Eur J Med Chem; 2021 Dec; 226():113866. PubMed ID: 34619466
[TBL] [Abstract][Full Text] [Related]
10. Carbamoylmannose enhances the tumor targeting ability of supramolecular nanoparticles formed through host-guest complexation of a pair of homopolymers.
Yao X; Zhu Q; Li C; Yuan K; Che R; Zhang P; Yang C; Lu W; Wu W; Jiang X
J Mater Chem B; 2017 Jan; 5(4):834-848. PubMed ID: 32263852
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of therapeutic efficacy of bleomycin by incorporation into biodegradable poly-d,l-lactic acid.
Kumanohoso T; Natsugoe S; Shimada M; Aikou T
Cancer Chemother Pharmacol; 1997; 40(2):112-6. PubMed ID: 9182831
[TBL] [Abstract][Full Text] [Related]
12. Role of carbohydrate moiety of bleomycin-A2 in caspase-3 activation and internucleosomal chromatin fragmentation in apoptosis of laryngeal carcinoma cells.
Brahim S; Abid K; Kenani A
Cell Biol Int; 2008 Feb; 32(2):171-7. PubMed ID: 17950632
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cellular uptake of carbamoylated mannose derivatives.
Elferink H; Geurts K; Jue S; MacCormick S; Veeneman G; Boltje TJ
Carbohydr Res; 2019 Jul; 481():67-71. PubMed ID: 31252337
[TBL] [Abstract][Full Text] [Related]
14. Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing rats.
Vos CM; Westera G
Eur J Nucl Med; 1982; 7(2):92-4. PubMed ID: 6177534
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of the antitumor antibiotic bleomycetin in cancer patients given the preparation by different methods].
Smolianskaia AZ; Spitsyna TA; Manziuk LV
Antibiotiki; 1984 Aug; 29(8):616-9. PubMed ID: 6207770
[TBL] [Abstract][Full Text] [Related]
16. Structures of HO(2)-Co(III)bleomycin A(2) bound to d(GAGCTC)(2) and d(GGAAGCTTCC)(2): structure-reactivity relationships of Co and Fe bleomycins.
Zhao C; Xia C; Mao Q; Försterling H; DeRose E; Antholine WE; Subczynski WK; Petering DH
J Inorg Biochem; 2002 Jul; 91(1):259-68. PubMed ID: 12121784
[TBL] [Abstract][Full Text] [Related]
17. Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity.
Norum OJ; Fremstedal ASV; Weyergang A; Golab J; Berg K
J Control Release; 2017 Dec; 268():120-127. PubMed ID: 29042319
[TBL] [Abstract][Full Text] [Related]
18. Folic acid conjugated nanoliposomes as promising carriers for targeted delivery of bleomycin.
Chiani M; Norouzian D; Shokrgozar MA; Azadmanesh K; Najmafshar A; Mehrabi MR; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):757-763. PubMed ID: 28643525
[TBL] [Abstract][Full Text] [Related]
19. Identification and cleavage site analysis of DNA sequences bound strongly by bleomycin.
Ma Q; Akiyama Y; Xu Z; Konishi K; Hecht SM
J Am Chem Soc; 2009 Feb; 131(5):2013-22. PubMed ID: 19146404
[TBL] [Abstract][Full Text] [Related]
20. Deglyco-peplomycin metal complexes on DNA fibers: a role of the sugar moiety for the stability and the orientation of the complexes.
Iiyama T; Chikira M; Oyoshi T; Sugiyama H
J Biol Inorg Chem; 2003 Jan; 8(1-2):135-40. PubMed ID: 12459908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
